Hosted on MSN1mon
Genetic mutation linked to higher SARS-CoV-2 riskThe paper, titled "Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene," is published in the journal Cellular and Molecular ...
At 12 months, 25.1% of patients starting tofacitinib and 30.1% of TNF inhibitor initiators achieved low disease activity. Tofacitinib demonstrated similar effectiveness to tumor necrosis factor (TNF) ...
Study: Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene. Image Credit: GB.JSTOCK / Shutterstock.com A recent study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results